{
  "paper_metadata": {
    "pmid": "33921571",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 18,
        "demographics": "Age at onset varied from 45 to 75 years (mean: 59.6)",
        "phenotype": "hATTR amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 18,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P10",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P11",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P12",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P13",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P14",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P15",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P16",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P17",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        },
        {
          "individual_id": "P18",
          "age_at_evaluation": 63,
          "age_at_onset": 59,
          "age_at_diagnosis": 62,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "hATTR amyloidosis",
          "evidence_sentence": "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified.",
      "evidence_level": "Not specified.",
      "source_location": "Results, paragraph 3.1",
      "additional_notes": "The study involved 18 patients with various TTR mutations.",
      "key_quotes": [
        "The 18 patients harbored six different TTR mutations: Phe64Leu (n.7), Glu89Gln (n.5), Val30Met (n.2), Thr49Ala (n.2), Val122Ile (n.1), and Ala109Ser (n.1)."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "TTR mutations in patients with hATTR amyloidosis",
      "variants_extracted": 6
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 6,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding TTR variants and penetrance were extracted."
  }
}